Navigation Links
Biotel Announces Profitable Second Quarter Ended December 31, 2008
Date:2/12/2009

MINNEAPOLIS, Feb. 12 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC Bulletin Board: BTEL) announced results for its second quarter ended December 31, 2008, with net earnings of $289,000, or $0.10 per diluted share, on revenues of $3,186,000. This compares to net earnings of $206,000, or $0.07 per diluted share, on revenues of $2,859,000 for the second quarter of last year. For the six months ended December 31, 2008, Biotel had net earnings of $617,000, or $0.22 per diluted share, on revenues of $6,354,000. This compares to net earnings of $376,000, or $0.13 per diluted share, on revenues of $5,610.000 for the first six months of last year.

    Highlights for the second quarter are as follows:

    * Ninth consecutive profitable quarter
    * Net income up 40.3% year over year
    * Strong gross margin of 45.9%, versus 44.7% a year ago
    * Strong balance sheet with no long-term bank debt
    * Stockholders' equity of $5,320,000, up 22.8% year over year

"We are pleased with Biotel's revenue growth, margin improvement and overall performance in the second quarter," Biotel President and CEO Steve Springrose said. "Sales of the Braemar ER920W wireless arrhythmia monitor remained strong as one of our OEM partners continued ordering product for inventory stocking. We expect sales to this customer to diminish in the second half. Sales of Braemar Holter devices, event recorders, liposuction equipment and other medical devices remained solid. Having received FDA 510(k) approval of our Fusion platform of wireless ECG monitoring products, we are beginning shipments of an evaluation version of the product this quarter, followed by a planned limited clinical release and distribution of Fusion products in our fourth quarter. Biotel serves as a development partner to medical corporations seeking new devices and clinical research services."



                               3 months ended  3 months en
'/>"/>
SOURCE Biotel Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Biotel Announces Profitable Third Quarter Ended March 31, 2008
2. Biotel Announces Strong Results for the Second Quarter Ended December 31, 2007
3. Biotel Announces Strong Results for the First Quarter Ended September 30, 2007, FDA 510(k) Clearance for the Braemar ER900 Wireless Event Recorder
4. Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
5. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Teleconference and Webcast
6. Investor Group Commends Jim Merselis for Joining Trinity Biotechs Board of Directors & Announces Conference Call Invitation
7. Cogdell Spencer Announces Dorr as President of the Southeast Region
8. ISTA Pharmaceuticals Announces Conference Call and Webcast of Fourth Quarter and Full-Year 2008 Financial Results
9. Terri Lynne Lokoff Child Care Foundation Announces Recipients of the 2009 Terri Lynne Lokoff/Childrens TYLENOL(R) National Child Care Teacher Awards(TM)
10. Webinar Alert: Coverity Announces Verification and Validation of Medical Device Software with Static Analysis - A Review of FDA Guidance and Best Practices
11. Dialysis Corporation of America Announces Fiscal Year 2008 Earnings Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 Alcohol and Violence ... (NCADD) notes that drinking and driving has been the ... the same time, the link between alcohol and crime ... abuse and violence and sexual assault, and their relationship ... the NCADD, 5.3 million adults in America were drinking ...
(Date:4/17/2015)... Sulphur Springs, Texas (PRWEB) April 17, 2015 ... (TLW) four years ago, the Texas non-profit organization has empowered ... part of its effort to bring fresh water and ... recently partnered with Liberty University. Between March 17 and 27, ... which will provide 7,000 Liberians with fresh water and the ...
(Date:4/17/2015)... Washington, DC (PRWEB) April 17, 2015 ... the HHT Diagnoses and Treatment Act HR 1849 in ... improve diagnosis rates and treatment for patients with the ... introduced in the past, would be the first to ... diagnoses and appropriate treatment of hereditary hemorrhagic telangiectasia. This ...
(Date:4/17/2015)... California (PRWEB) April 17, 2015 At ... Entertainment’s EcoLuxe Lounge and the “Salute to the Oscars” ... luxurious Beverly Hilton Hotel, overlooking the impressive Los Angeles ... were organized by Debbie Durkin, LA’s leading producer of ... Showcasing many of the world’s premier providers of eco-friendly ...
(Date:4/17/2015)... Baptist Health and The University of Texas ... designed to transform oncology care in northeast Florida and ... create a joint cancer program to enhance patient access ... MD Anderson Cancer Center is anticipated to open in ... highly coordinated, multidisciplinary cancer care for adults in the ...
Breaking Medicine News(10 mins):Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3
... MYL ),today announced that Mylan Pharmaceuticals Inc. has ... (FDA) for its Abbreviated New,Drug Application (ANDA) for Cetirizine ... HCl Tablets are the generic version of Pfizer,s Zyrtec(R),Tablets, ... the 12,months ending Sept. 30, 2007., This product ...
... 28, 2007 Laser surgery to correct vision problems ... Keratotomy (PRK) is typically used to correct low to ... for high myopia corrections. Although over 18 million LASIK ... controversy regarding the maximum correction possible and efficacy with ...
... patients than are other doctors, study finds , , THURSDAY, ... of spirituality and faith when interacting with patients, but ... finds. , In fact, more than 90 percent of ... ask patients about their religious faith or spirituality, while ...
... 27 The National Drug,Intelligence Center (NDIC), ... and,the nation,s principal center for strategic drug ... Assessment. This strategic,assessment presents an analysis of ... distribution, and abuse in the,United States. The ...
... Dec. 27 Like a lot of Americans, ... healthier your New Year,s resolution -- but,it,s important ... off by January,2nd., Listen to this report ... can access video, audio, text, graphics and,photos for ...
... Practice in Hudson is the Only Accredited Lab in Summit County ... ... Dec. 27 Western Reserve Heart Care, a,cardiology testing and treatment ... echocardiography lab by the,Intersocietal Commission for the Accreditation of Echocardiography,Laboratories (ICAEL)., ...
Cached Medicine News:Health News:LASIK works well, according to long-term study of highly myopic patients 2Health News:Most Psychiatrists Open to Discussing Spiritual Concerns 2Health News:Most Psychiatrists Open to Discussing Spiritual Concerns 3Health News:National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment 2Health News:Western Reserve Heart Care Receives ICAEL Echocardiography Accreditation 2
(Date:4/17/2015)... N.C. , April 17, 2015 ... the Integrated Embolic Protection™ filter platform for angioplasty ... of a $5.6 million Series B financing round ... venture firm with a focus on medical devices, ... The round also included Mountain Group Partners, Lookout ...
(Date:4/17/2015)... CHICAGO, Ill. , April 17, 2015  AbbVie Inc. ... today announced that it has extended the expiration of its ... common stock of Pharmacyclics, Inc. to 5 p.m., ... On April 17, 2015, AbbVie also voluntarily ... Antitrust Improvements Act in order to provide the FTC with ...
(Date:4/17/2015)... April 17, 2015 Inivata, a ... today that their presence at the 2015 American Association for ... by co-founder Nitzan Rosenfeld and a poster presentation. ... 18 th - 22 nd . The ... ctDNA , forms part of a session on ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2
... survival advantage ... standard therapy, -- First study to show survival advantage ... Pharmion Corporation,(Nasdaq: PHRM ) today announced that the ... approval of Thalidomide,Pharmion(R) for use in combination with melphalan and ...
... Appoints U.S. Biotest to Oversee Trials, PRINCETON, ... Board: DSCI), a provider of advanced wound care ... services agreement with San,Luis Obispo-based, privately held U.S. ... of DSC127, a novel and rapid wound-healing and,scar-reduction ...
Cached Medicine Technology:Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 2Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 3Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 4Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 5Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency 6Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 2Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 3Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells 4
Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
The cementless acetabular shells form part of the Mallory head range of femoral and acetabular implants....
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
Medicine Products: